Palo Alto Investors

Palo Alto Investors is an investment advisor providing money management services.

Business Model:

Revenue: $13M

Employees: 51-200

Rankings

Detailed Palo Alto Investors Information

Geographic Data

Palo Alto Investors headquarters map

Address: 470 University Ave

City: Palo Alto

State: CA

Zip: 94301

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$40M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Palo Alto Investors is an investment advisory company that provides money management services. It also operates as a private investment firm that offers long-term investments for high-net-worth and institutional investors based on original and fundamental research. Palo Alto Investors was founded in 1989 and is based in Palo Alto, California.

Contact Phone:
+16503250772

Contact Email:

Announced Date Company Transaction Money Raised
12/2009 Revance Therapeutics Series D 0
1/2001 Labcyte Series A -
7/2002 Labcyte Series B 22M
8/2011 Ceptaris Therapeutics Series D 14.4M
6/2012 Ceptaris Therapeutics Series D 10M
1/2014 NeXeption Series A 21.5M
12/1999 Conductus Debt Financing 15M
11/2005 FlowMedica Series D 0
4/2001 Speedera Networks Venture Round 0
11/2022 Peak Bio Post-IPO Equity 25M
12/2007 Fisker Automotive Series A 5.5M
6/2007 Paracor Medical Series D 44M
11/2007 Ceptaris Therapeutics Series C 14.5M
5/2005 SkyPilot Networks Series C 15M
7/2006 SkyPilot Networks Venture Round 21M
12/2001 SkyPilot Networks Series B 24.4M
1/2003 Lumend Series D 23.2M
9/2005 Amicus Therapeutics Series C 55M
9/2007 Gemfire Venture Round 0
7/2012 Alimera Sciences Post-IPO Equity 40M
1/2008 Fisker Automotive Series B 20M
5/2021 Gilgamesh Pharmaceuticals Series A 0
2/2011 Fisker Automotive Private Equity Round 0
5/2005 Talima Therapeutics Series A 1.6M
6/2011 Revance Therapeutics Series D 45M
9/2006 Amicus Therapeutics Series D 60M
9/2008 Fisker Automotive Series C 0
5/2006 Mercator MedSystems Series A 2.3M
12/2007 Revance Therapeutics Series C 0
9/2014 NewLeaf Symbiotics Series B 0
6/2005 Deem Series B 0
5/2021 Gilgamesh Pharmaceuticals Series A 0
9/2014 NewLeaf Symbiotics Series B 0
1/2014 NeXeption Series A 0
7/2012 Alimera Sciences Post-IPO Equity 0
6/2012 Ceptaris Therapeutics Series D 0
8/2011 Ceptaris Therapeutics Series D 0
6/2011 Revance Therapeutics Series D 0
2/2011 Fisker Automotive Private Equity Round 0
12/2009 Revance Therapeutics Series D 0
9/2008 Fisker Automotive Series C 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research